» Articles » PMID: 10904122

Total Sleep Deprivation Combined with Lithium and Light Therapy in the Treatment of Bipolar Depression: Replication of Main Effects and Interaction

Overview
Journal Psychiatry Res
Specialty Psychiatry
Date 2000 Jul 25
PMID 10904122
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical usefulness of total sleep deprivation (TSD) in the treatment of bipolar depression is hampered by a high-rate short-term relapse. Previous literature has suggested that both long-term lithium treatment and light therapy could successfully prevent relapse. We randomized 115 bipolar depressed inpatients to receive three cycles of TSD, alone or in combination with morning light exposure, given at an intensity of 150 or 2500 lux. Forty-nine patients were undergoing long-term treatment with lithium salts (at least 6 months), while 66 patients were taking no psychotropic medication. Mood was self-rated by the Visual Analogue Scale three times a day during treatment. The results showed that both light therapy and ongoing lithium treatment significantly enhanced the effects of TSD on the perceived mood, with no additional benefit when the two treatments were combined. Subjective sleepiness during TSD, as rated by the self-administered Stanford Sleepiness Scale, was significantly reduced by light exposure, and was correlated with the outcome. This study confirms the possibility of obtaining a sustained antidepressant response to TSD in bipolar patients.

Citing Articles

Fast depressive symptoms improvement in bipolar I disorder after Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT): A two-site feasibility and safety open-label trial.

Li K, Bichlmeier A, DuPont C, Siegel-Ramsay J, Comfort A, Logue E J Affect Disord. 2024; 365:359-363.

PMID: 39154984 PMC: 11495146. DOI: 10.1016/j.jad.2024.08.087.


Effects of bright light therapy on neuroinflammatory and neuroplasticity markers in a diurnal rodent model of Seasonal Affective Disorder.

Costello A, Linning-Duffy K, Vandenbrook C, Lonstein J, Yan L Ann Med. 2023; 55(2):2249015.

PMID: 37625385 PMC: 10461522. DOI: 10.1080/07853890.2023.2249015.


Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.

Recourt K, de Boer P, Van Der Ark P, Benes H, van Gerven J, Ceusters M Transl Psychiatry. 2023; 13(1):266.

PMID: 37482560 PMC: 10363543. DOI: 10.1038/s41398-023-02557-5.


Sleep-light interventions that shift melatonin rhythms earlier improve perimenopausal and postmenopausal depression: preliminary findings.

Parry B, Meliska C, Sorenson D, Martinez L, Lopez A, Dawes S Menopause. 2023; 30(8):798-806.

PMID: 37463404 PMC: 10524957. DOI: 10.1097/GME.0000000000002216.


A 1-week sleep and light intervention improves mood in premenstrual dysphoric disorder in association with shifting melatonin offset time earlier.

Parry B, Meliska C, Martinez L, Lopez A, Sorenson D, Dawes S Arch Womens Ment Health. 2022; 26(1):29-37.

PMID: 36520251 PMC: 9908689. DOI: 10.1007/s00737-022-01283-z.